文献速递中毒与环境急症消化、代谢与肾脏急症

急诊科基于最佳实践顾问激活的「纳洛酮到手」发放项目效果

Effect of a best practice advisory activated "kit in hand" naloxone distribution program in the emergency department.
PubMed 文献 · Am J Emerg Med · 2024-11-23
一句话结论急诊科对意外阿片类药物过量成人实施BPA激活的纳洛酮到手发放项目后,成功获得纳洛酮比例从15.6%升至56.6%。

该研究为回顾性观察性研究,纳入6个月内急诊科意外阿片类药物过量成人患者349例,比较BPA激活的鼻内纳洛酮「到手」发放项目实施前后纳洛酮发放情况。实施前160例中25/160(15.6%)获得纳洛酮;实施后189例中106/189(56.1%)离院时手持纳洛酮套件,另有1/22例开具处方者确认取药,合计107/189(56.6%)获得纳洛酮。实施后未获得套件的原因包括患者拒绝(6.3%)、患者已有纳洛酮(1.6%)或改为开具处方(11.6%)。作者认为该项目提高了这一过量复发极高危亚人群的纳洛酮成功发放率,并发现流程中仍存在障碍。

要点

  • 实施BPA激活的「到手」发放项目后,急诊意外阿片类药物过量成人获得纳洛酮的比例从15.6%(25/160)升至56.6%(107/189)。
  • 实施前68.1%(109/160)患者出院时获得纳洛酮处方,但仅22.9%(25/109)确认取药,实际获得纳洛酮者仅15.6%(25/160)。
  • 实施后56.1%(106/189)患者离院时手持纳洛酮套件,另1/22例开具处方者确认取药,合计56.6%(107/189)。
  • 实施后未获得套件的原因:患者拒绝6.3%、患者已有纳洛酮1.6%、改为开具处方11.6%。
  • 实施后存在临床医生意图开具或已开具但护理未发放套件的情况,提示流程障碍。

适用人群与场景

  • 成人急诊科患者,意外阿片类药物过量,研究为期六个月。
  • 实施前组160例(中位年龄39.5岁,男性74.4%,白人63.1%,非西班牙裔83.7%);实施后组189例(中位年龄41岁,男性75.7%,白人52.9%,非西班牙裔81.5%)。

处置流程与药物剂量

  • 在急诊科离院时,通过电子健康记录最佳实践顾问(BPA)激活鼻内纳洛酮「到手」发放项目。
  • 实施后未发放套件的原因包括患者拒绝(6.3%)、患者已有纳洛酮(1.6%)或改为开具处方(11.6%)。

研究设计与关键结果

  • 回顾性观察性研究,纳入349例成人急诊意外阿片类药物过量患者,比较BPA激活的鼻内纳洛酮「到手」发放项目实施前(160例)与实施后(189例)的纳洛酮发放情况。
  • 实施前:109/160(68.1%)出院时获得纳洛酮处方,其中25/109(22.9%)确认取药,总获得纳洛酮者25/160(15.6%)。
  • 实施后:106/189(56.1%)离院时手持纳洛酮套件,另1/22例开具处方者确认取药,总获得纳洛酮者107/189(56.6%)。
  • 实施后未获得套件原因:患者拒绝6.3%、患者已有纳洛酮1.6%、改为开具处方11.6%。
  • 存在临床医生记录意图开具或已开具套件但护理未发放的情况。
  • 实施后组中,比较临床医生意图让患者获得纳洛酮与无此意图者,年龄、性别、种族、民族或离院时间均无差异。

证据类型、等级与局限

  • 证据类型:回顾性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,实施BPA激活的「到手」纳洛酮发放项目可提高急诊意外阿片类药物过量患者纳洛酮成功发放率,该亚人群过量复发风险极高。
  • 作者指出项目仍有改进机会,因存在意图发放但流程障碍导致套件未发放的情况。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: We implemented a "kit in hand" naloxone distribution program at emergency department (ED) discharge activated by electronic health record Best Practice Advisory (BPA). The purpose of this study was to evaluate naloxone kit distribution before and after implementation.

METHODS: Retrospective observational study of adult ED patients with unintentional opioid overdose conducted over a six-month period. An intranasal (IN) naloxone kit in hand distribution program activated by BPA was implemented during the study period. Patient demographics and reasons eligible patients did not receive a kit are reported. Multivariable regression was performed to identify differences in patients that received naloxone or were intended to receive it compared to those that were not to identify any biases in distribution.

RESULTS: A total of 349 patients were included; 160 pre- (median age 39.5 years, 74.4 % males, 63.1 % white, 83.7 % non-Hispanic) and 189 post-implementation (median age 41 years, 75.7 % males, 52.9 % white, 81.5 % non-Hispanic). Pre-implementation, 109/160 (68.1 %) patients received a naloxone prescription at discharge with only 25/109 (22.9 %) confirmed to have picked up the naloxone kit and therefore a total of 25/160 (15.6 %) receiving naloxone. Post-implementation, 106/189 (56.1 %) patients left the ED with a naloxone kit in hand and 1/22 additional patients that had a prescription written were confirmed to have picked it up; therefore, a total of 107/189 (56.6 %) receiving naloxone. Reasons for not receiving a naloxone kit in the post-implementation period were patient refusal (6.3 %), patient already had naloxone (1.6 %), or a prescription was written instead (11.6 %). There were instances where kits were intended to be ordered based on clinician notes or naloxone kit was ordered but not dispensed by nursing staff. There were no differences between age, sex, race, ethnicity, or time of discharge from the ED following comparison of those where the clinician intended for the patient to receive naloxone and those where there was not intent to prescribe naloxone in the post-implementation group.

CONCLUSIONS: Implementation of a BPA-activated kit in hand naloxone distribution program increases the rate of successful naloxone distribution to patients presenting to the ED following unintentional opioid overdose, a subpopulation at very high risk for recurrence of overdose. Opportunities for program improvement were identified as there were instances where kits were intended to be distributed but barriers in the process existed.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Dash S, Acquisto NM, McElliott J, et al. Effect of a best practice advisory activated "kit in hand" naloxone distribution program in the emergency department. Am J Emerg Med. 2024. PMID: 39615436. doi:10.1016/j.ajem.2024.11.065

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。